Soriano, Mofel .
HRN: 27-44-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2025
MUPIROCIN 2%, 15G (TUBE)
07/08/2025
07/14/2025
TOPICAL
2%
OD
Post Op
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes